Clinical Trial Update: Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and tolerability of fetal mesencephalic dopamine neuronal precursor cells for Parkinson's disease (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease
• Parkinsonism

Drugs mentioned

• fetal mesencephalic dopamine neuronal precursor cells

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Idiopathic Parkinson Disease, Primary Parkinsonism | Phase 1, Phase 2 | Status: UNKNOWN